Hepatitis C in Developing Countries

Current and Future Challenges

Nonfiction, Science & Nature, Science, Biological Sciences, Microbiology, Health & Well Being, Medical
Cover of the book Hepatitis C in Developing Countries by , Elsevier Science
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9780128032343
Publisher: Elsevier Science Publication: November 23, 2017
Imprint: Academic Press Language: English
Author:
ISBN: 9780128032343
Publisher: Elsevier Science
Publication: November 23, 2017
Imprint: Academic Press
Language: English

Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1.

  • Features coverage on the prevention of, or inhibition of, liver fibrosis, cirrhosis, and hepatocellular carcinoma
  • Presents data from trials on patients with diverse ethnic backgrounds and those infected with genotypes 3, 4, 5, 6
  • Addresses the epidemiology, modes of transmission, socio-political aspects, genotypes, and co-infections of Hepatitis C
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Hepatitis C in Developing Countries: Current and Future Challenges explores the current state of HCV in several countries, including Africa, Asia and South America. It maintains a dedicated focus on the epidemiology, clinical patterns, virologic diversity, coinfections, natural history and progression, complications, and response to standard of care (SOC) pegylated interferon and ribavirin therapy of HCV with recommendations specific to middle and low income countries. Readers will find detailed information on the burden of HCV infection from a global health and economic perspective, along with data from multicenter trials on DAAs that have enrolled patients infected with HCV non-genotype 1.

More books from Elsevier Science

Cover of the book Marketing the 21st Century Library by
Cover of the book Stochastic Crack Propagation by
Cover of the book Advances in Geophysics by
Cover of the book Advances in Pharmacology by
Cover of the book Fluoropolymer Applications in the Chemical Processing Industries by
Cover of the book Doping, Performance-Enhancing Drugs, and Hormones in Sport by
Cover of the book Health Professionals' Education in the Age of Clinical Information Systems, Mobile Computing and Social Networks by
Cover of the book The Microwave Processing of Foods by
Cover of the book Molecular and Laser Spectroscopy by
Cover of the book Pedogenesis and Soil Taxonomy: Concepts and Interactions by
Cover of the book The Future of Soil Carbon by
Cover of the book Personnel Protection: Advance Procedures by
Cover of the book Nanoencapsulation of Food Bioactive Ingredients by
Cover of the book The Ecology of Large Mammals in Central Yellowstone by
Cover of the book NMR Metabolomics in Cancer Research by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy